APA (7th ed.) Citation

Southern California Evidence-Based Practice Center/RAND, United States. Agency for Healthcare Research and Quality, & Newberry, S. J. (2004). Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis. U.S. Dept. of Health and Human Services, Public Health Service, Agency for Healthcare Research and Quality.

Chicago Style (17th ed.) Citation

Southern California Evidence-Based Practice Center/RAND, United States. Agency for Healthcare Research and Quality, and Sydne J. Newberry. Effects of Omega-3 Fatty Acids on Lipids and Glycemic Control in Type II Diabetes and the Metabolic Syndrome and on Inflammatory Bowel Disease, Rheumatoid Arthritis, Renal Disease, Systemic Lupus Erythematosus, and Osteoporosis. Rockville, Md: U.S. Dept. of Health and Human Services, Public Health Service, Agency for Healthcare Research and Quality, 2004.

MLA (9th ed.) Citation

Southern California Evidence-Based Practice Center/RAND, et al. Effects of Omega-3 Fatty Acids on Lipids and Glycemic Control in Type II Diabetes and the Metabolic Syndrome and on Inflammatory Bowel Disease, Rheumatoid Arthritis, Renal Disease, Systemic Lupus Erythematosus, and Osteoporosis. U.S. Dept. of Health and Human Services, Public Health Service, Agency for Healthcare Research and Quality, 2004.